Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

<b>Practice Tip: </b> Dealing with the Surprise Government Interview

By David M. Rosenfield and James A. Moss
September 28, 2007

This article will help companies and their employees prepare for and, if necessary, deal with, a surprise interview by government agents conducted as part of an investigation of an allegedly defective product.

Periodically, the government conducts criminal investigations into alleged product defects. For example, as The Washington Post recently reported, the U.S. Food and Drug Administration has opened a criminal investigation into the highly publicized case involving the contamination of pet food, in which various pet food companies determined that they had used melamine-contaminated ingredients from China in their products. (Patricia Sullivan, Criminal Probe Opened in Pet Food Scare, www.washingtonpost.com, April 21, 2007) Investigations such as this one are not isolated events. As noted in a paper issued in 2001 by the National Legal Center for the Public Interest:

The product liability arena has long been subject to criminalization ' High-
profile, product liability tragedies have incited legislatures to take aim directly at CEOs. The media routinely has pounced on product liability crises ' to bash big business. In turn, society has demanded that someone 'pay the price.' Legislators, representing constituents who are thirsty for retribution, have targeted not only corporations but also their CEOs. After all, someone needs to be held accountable.

(Stanley A. Twardy, Jr., et al., The Criminalization of the CEO, National Legal Center for the Public Interest, March 2001; see also Press Release
of national nonprofit consumer advocacy organization Public Citizen, 'Public Citizen Calls for Criminal Investigation of Breast Implant Manufacturer for Withholding Safety Data from FDA,' www.citizen.org, Oct. 12, 2006; Consumer Product Safety Act, 15 U.S.C. ”2068, 2070; Federal Food, Drug, and Cosmetic Act, 21 U.S.C. ”331, 333).

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The Bankruptcy Hotline Image

Recent cases of importance to your practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

How AI Has Affected PR Image

When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.